USANA Health Sciences Inc (USNA)
Solvency ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.27 | 1.28 | 1.29 | 1.33 | 1.37 | 1.35 | 1.38 | 1.47 | 1.46 | 1.45 | 1.41 | 1.45 | 1.45 | 1.48 | 1.47 | 1.49 | 1.47 | 1.47 | 1.39 | 1.41 |
The solvency ratios of USANA Health Sciences Inc, as represented by the debt-to-assets ratio, debt-to-capital ratio, debt-to-equity ratio, and financial leverage ratio, have consistently shown a low or zero level of debt relative to the company's assets, capital, and equity over the past few quarters. This indicates that the company relies less on debt financing and has a strong financial position in terms of solvency.
Additionally, the financial leverage ratio has fluctuated slightly over the period, with the highest ratio observed in March 2022 and the lowest in December 2019. The increasing trend from 2021 to 2022 suggests a slight rise in the company's reliance on financial leverage, which should be monitored to ensure it does not lead to financial strain.
Overall, based on the solvency ratios analyzed, USANA Health Sciences Inc appears to have a stable and healthy financial position with minimal debt obligations relative to its assets, capital, and equity.
Coverage ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 392.04 | 663.04 | 735.33 | 544.64 | 566.73 | 660.92 | 821.68 | 1,900.92 | 2,994.72 | — | 681.87 | 373.96 | 351.98 | 104.37 | 571.33 | 2,045.87 | 2,281.24 | 2,909.62 | 4,226.51 | 4,838.18 |
The interest coverage ratio measures a company's ability to pay interest expenses on outstanding debt. A higher interest coverage ratio indicates a stronger ability to cover interest payments.
Analyzing USANA Health Sciences Inc's interest coverage over the past 5 quarters, we observe a fluctuating trend. The company's interest coverage ratio reached its peak at 4,838.18 in Q2 2019, indicating a very strong ability to cover interest expenses. However, the ratio dropped significantly in subsequent quarters but remained above 100, signaling a robust capacity to pay interest.
In the most recent quarter, Dec 2023, USANA Health Sciences Inc's interest coverage ratio stood at 392.04, reflecting a decrease from the previous quarter but still indicating a healthy ability to meet interest obligations.
Overall, despite some fluctuations, USANA Health Sciences Inc maintains a generally solid interest coverage ratio, suggesting a strong financial position in terms of meeting interest payment obligations.